Abstract:NF-kappa B activation is known to reduce the efficiency of chemotherapy in cancer treatment. Ursolic acid, a minimally toxic compound, has shown the capability to inhibit NF-kappa B activation in living cells. Here, for the first time, we investigated the effects and mechanisms of NF-kappa B inhibition by ursolic acid on chemotherapy treatment (Taxol or cisplatin) of cancer. ASTC-a-1 (human lung adenocarcinoma), He la (human cervical cancer) cells, primary normal mouse cells of lung and liver and mouse in vivo model were used. Activity of signal factors (NF-kappa B, Akt, Fas/FasL, BID, Bcl-2, cytochrome c and caspase-8, 3) was used to analyze the mechanisms of ursolic acid-chemo treatment. Ursolic acid-mediated suppression of NF-kappa B drastically reduced the required dosage of the chemotherapeutic agents to achieve identical biological endpoints and enhanced the chemotherapeutic agent-induced cancer cells apoptosis. Chemosensitization by ursolic acid in cancer cells was dependent on the amplified activation of intrinsic pathway (caspase-8-BID-mitochondria-cytochrome c-caspase-3) by augmentation of BID cleavage and activation of Fas/FasL-caspase-8 pathway. Prolonged treatment with relatively low doses of ursolic acid also sensitized cancer cells to the chemotherapeutic agents through suppression of NF-kappa B. Chemosensitization by ursolic acid was observed only in cancer cells, but not in primary normal cells. The inhibitive effect of ursolic acid on NF-kappa B was reversible, and the reversal was not accompanied by a loss in cells viability. By supplementing chemotherapy with minimally toxic ursolic acid, it is possible to improve the efficacy of cancer treatment by significantly reducing the necessary drug dose without sacrificing the treatment results.

Discovery of Antitumor Ursolic Acid Long-Chain Diamine Derivatives As Potent Inhibitors of NF-κB.

Side Chain-Functionalized Aniline-Derived Ursolic Acid Derivatives As Multidrug Resistance Reversers That Block the Nuclear Factor-Kappa B (Nf-Κb) Pathway and Cell Proliferation.

The Analysis of the Anti-Tumor Mechanism of Ursolic Acid Using Connectively Map Approach in Breast Cancer Cells Line MCF-7

Antitumor Agents 295. E-ring Hydroxylated Antofine and Cryptopleurine Analogues As Antiproliferative Agents: Design, Synthesis, and Mechanistic Studies.

Synthesis and Antitumor Activity Evaluation of Novel Ursolic Acid Derivatives

Glycyrrhetinic Acid Derivatives Containing Aminophosphonate Ester Species As Multidrug Resistance Reversers That Block the NF-κB Pathway and Cell Proliferation.

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Synthesis and Identification of New 4-Arylidene Curcumin Analogues As Potential Anticancer Agents Targeting Nuclear Factor-Κb Signaling Pathway.

Design, Synthesis, and Biological Evaluation of Novel Nitrogen Heterocycle-Containing Ursolic Acid Analogs as Antitumor Agents

Synthesis of [3Β-Acetoxy-urs-12-en-28-oyl]-1-monoglyceride and Investigation on Its Anti Tumor Effects Against BGC-823.

Enhancement Of Chemotherapeutic Agent-Induced Apoptosis By Inhibition Of Nf-Kappa B Using Ursolic Acid

Synthesis and Anti-Tumor Activity of Derivatives of Ring A of Ursolic Acid

Synthesis and Discovery of Asiatic Acid Based 1,2,3-Triazole Derivatives As Antitumor Agents Blocking NF-κB Activation and Cell Migration

Discovery of 5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)-1H-indole-2-carboxamide derivatives as novel anti-cancer agents targeting Nur77

Synthesis and Evaluation of Ursolic Acid Derivatives As Potent Cytotoxic Agents.

Design, Synthesis, and Evaluation of Asymmetric EF24 Analogues As Potential Anti-Cancer Agents for Lung Cancer.

Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs

Discovery of Novel Small-Molecule Inhibitors of NF-κB Signaling with Antiinflammatory and Anticancer Properties.

Discovery of 1,3,4-Oxadiazole Derivatives As Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction

Design and synthesis of 2,3-dihydro- and 5-chloro-2,3-dihydro-naphtho-[1,2-b]furan-2-carboxylic acid N-(substitutedphenyl)amide analogs and their biological activities as inhibitors of NF-κB activity and anticancer agents

Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.